A Biotech Bash - Recs and Wrecks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : A Biotech Bash - Recs and Wrecks

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ryan Weisman who wrote (108)	9/2/1997 8:49:00 AM
From: MarcG	of 171

Have a great morning Ryan. Great to hear back from you. I was so dog tired from all the Labor Day BBQ's this weekend that I had to catch up on some zzzzz's. Very important to watch volume, as you observed, and relationship to price. I, too, would like to see some 100-200k volume days accompanied by 1/4 point gains. Maybe the market views this as a one product company, which it definitely isn't. True its field of study is nucleic acids, but this Beaufour news only exemplifies the variety of applications for Ampligen. Since they are working on HIV, CFS, and Hepatitis, I think their chances of success may be heightened. In a world of instant this and that, I agree with you that something is lagging. But not even the advent of the internet can control time or human emotions. Many stories still lag or nobody cares. Judging from the recent past, $3 bids may provide an early clue if this is about to change for HEMX. MG:

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next